Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral research

Not Applicable

• Conditions: Breast cancer

• Registration Number: JPRN-UMIN000042055
• Lead Sponsor: Japan Agency for Medical Research and Development

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-09
• Study Completion: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: Female
• Target Recruitment: 107

Inclusion Criteria

Not provided

Exclusion Criteria

Cases considered by the attending physician to be unsuitable for enrollment in this study

Study & Design

• Study Type: Observational
• Study Design: Not specified